Onychomycosis due to non-dermatophytic fungi is a well-known and increasingly common infection. For the fi rst time ever, we report two cases of onychomycosis caused by Aspergillus persii, a recently described new Aspergillus species. After ten and three years respectively, both patients showed relapsing nail infections, and mycological tests were still positive for A. persii. In vitro antifungal susceptibility tests demonstrated that both strains were only susceptible to itraconazole, voriconazole, posaconazole and terbinafi ne of the agents tested.
Case report 1
In 1999, a 61-year-old female with a suspected onychomycosis of the left big toe was examined at the Dermatology Unit of S. Martino Hospital in Genoa. Despite a previous therapeutic onychocectomy, the patient had suffered from a nail infection of the left big toe since the age of 40. The dermatological examination showed involvement of the nail lamina of her left big toe, suggestive for a distal lateral subungual onychomycosis. Discolouration was present on the free edge of the nail plate, as well as near the lateral nail fold, where the nail lamina was severely damaged. The invasion of the nail plate was associated with a subungual hyperkeratosis (Fig. 1) .
Direct microscopic analysis of the nail revealed fungal fi laments and inoculation of portions of the nail on modifi ed Sabouraud medium (1.5% agar, 2% glucose, 1% neopeptone) yielded a yellow mould, with general morphological characters matching those of members of the genus Aspergillus P. Micheli ex Link, section Circumdati
Introduction
Onychomycoses are nail infections usually caused by dermatophytic fungi, but in recent years many authors have reported an increasing number of cases involving nondermatophytes [1] [2] [3] [4] . Due to this particular aetiology, only a reduced number of the antifungal drugs usually effective with dermatophytic fungi, has a spectrum that includes non-dermatophytic agents of onychomycosis.
Aspergillus is a well known cause of pulmonary and invasive infections, especially in immunocompromised hosts. While there is a lower number of reports regarding onychomycosis caused by Aspergillus, this might be the result of the inherent diffi culties in distinguishing a true Aspergillus nail infection from the presence of the fungus as a contaminant. Moreover, the identifi cation of nondermatophytic fungi recovered from cases of onychomycosis, in particular Aspergillus spp., usually stops at the genus level [3] [4] [5] . The absences of species identifi cation (Fig. 2) . The analysis of additional features, especially the small size of conidial heads, vesicles and club-like enlargements, together with the production of secondary metabolites, led to the isolate's identifi cation as Aspergillus persii, a new species described in detail in 2002 [6] . Subcultures of the isolate were deposited at the Mycotheque de l'Université Catholique de Louvain, Louvain-la-Neuve, Belgium (MUCL 41970), at the Centraalbureau voor Schimmelcultures, Utrecht, The Nederlands (CBS 112795), and at the Mycotheca Universitatis Taurinensis, Turin, Italy (MUT 3318). The sequence of b-tubulin gene was deposited at GenBank (AY819988) by other authors [7] .
The application of nail enamel containing 28% tioconazole was the fi rst therapeutic approach, but it proved to be unsuccessful. Even the results of a second local therapeutic attempt, based on a nail varnish containing 5% amorolfi ne, were disappointing as well. Finally, we attempted a combination of local and oral therapies. The fi rst step consisted of cleaning the infected portion of the nail lamina by means of a dental milling cutter. After full abrasion up to the nail bed, an ointment containing 1% amphotericin B was applied (since this product was not available in Italy, it was prepared as a galenic formulation). In addition, a daily oral dose of terbinafi ne (250 mg) was administered for three months. As a result of this combined approach, the patient slowly improved and achieved the clinical recovery in two years.
The patient remained stable for many years throughout follow-up, but probable relapse was noted in November 2008. Microscopic examination in January 2009 of the nail revealed a fi lamentous fungus and Aspergillus persii was again recovered in culture.
Case report 2
In June 2006, a 56-year-old male was examined due to a suspected onychomycosis of both the big toes at the same Dermatology Unit that was involved in Case 1. Although the patient did not have diabetes mellitus or any immunological disease disorder, he reported having infections of both big toe nails since 2005. Distal lateral type lesions affected the nail laminas of both toes and the nail plates were dystrophic to the same degree, maybe due to a direct action of the fungus or to minor nail traumas.
Nail samples from both toes were microscopically examined and inoculated on Sabouraud dextrose agar. While the microscopic analysis did not reveal the presence of fungi, A. persii was recovered in culture. Since positive cultures were not confi rmed by direct microscopic analysis, a subsequent dermatological examination was planned to ascertain the identifi cation of the etiologic agent. However, as the patient was abroad at that time, new examinations could only be performed prior to September 2006. The second direct microscopic examination revealed fi lamentous fungi and A. persii was again found in repeated cultures.
The sequence of the b-tubulin gene was obtained in order to confi rm the identifi cation. Total fungal genomic DNA was isolated by means of Qiagen DNeasy Plant Mini Kit® (QIAGEN GmbH, Hilden, Germany) according to the manufacturer's instructions. Amplifi cation of b-tubulin gene was performed by using Bt2a and Bt2b primers [8] . Amplification was performed in a Biometra T3000 Thermocycler (Biometra biomedizinische Analytik GmbH, Goettingen Germany) programmed as follows: -1 cycle of 3 min denaturation at 95°C; -35 cycles of 40 s denaturation at 94°C, primer annealing 45 s at 55°C, primer extension 1 min at 72°C; -Final 10 min elongation step at 72°C. DNA sequencing was performed by DiNAMYCODE s.r.l. (DiNAMYCODE, Turin, Italy) . Sequence data, submitted to known sequence databases (NCBI/BLASTN algorithm), together with morphological data, confi rmed the identifi cation of the etiologic agent as Aspergillus persii.
Living cultures of this second A. persii strain were deposited at the Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands (CBS 124573), and at the Mycotheca Universitatis Taurinensis, Turin, Italy (MUT 4189). The sequence of b-tubulin gene was deposited at GenBank (GQ850380).
The patient was treated with both local and systemic therapy. Local therapy consisted of softening the nail plate with 50% urea and then applying 5% amorolfi ne enamel. Systemic therapy involved the daily administration of 400 mg of itraconazole for 1 week per month for 6 months (pulsed therapy). After this treatment the patient improved and fi nally reached clinical recovery.
Follow-up was uneventful until February 2009, when the big toes again showed nail lamina infections. A complete mycological examination was performed and A. persii was isolated again but the patient refused to start another therapeutic attempt.
Antifungal susceptibility testing
The in vitro antifungal drug susceptibility of isolates of A. persii from both cases was investigated by the following two methods:
Microdilution method
The broth microdilution method was performed according to CLSI document M38-A2 guidelines [9] using RPMI 1640 medium supplemented with 2% glucose. Inocula suspensions were prepared from 7-day-old cultures grown on potato dextrose agar and adjusted spectrophotometrically to optical densities from 0.09 to 0.17 (68-82% transmittance). The fi nal inocula ranged from 0.5 ϫ 10 4 to 5 ϫ 10 4 CFU/ml, as demonstrated by quantitative colony counts. As recommended, colonies were counted as soon as possible after growth became visible.
The antifungals employed were amphotericin B, itraconazole, fl uconazole, voriconazole, posaconazole, caspofungin and terbinafi ne. Drug concentration ranged from 0.125-256 μg/ml for fl uconazole and from 0.008-16 μg/ml for itraconazole, voriconazole, posaconazole, caspofungin and amphotericin B and from 0.03-16 μg/ml for terbinafi ne.
The inoculated microdilution trays were incubated at 35°C and read after 48 h. The MIC endpoint for the azoles, amphotericin B and terbinafi ne was defi ned as the lowest concentration that produced complete inhibition of growth, whereas with fl uconazole it was the level at which 50% inhibition was observed. The minimum effective concentration (MEC) endpoint for caspofungin was defi ned as the lowest concentration at which an abnormal growth was found.
Aspergillus fl avus ATCC 204304 and A. fumigatus ATCC 204305 were employed as controls and results were within the recommended limits of the CLSI procedure.
Sensititre YeastOne® method
Sensititre YeastOne® panels (Trek Diagnostic Systems) was the second method for evaluation of antifungal susceptibility patterns. Inocula suspensions were prepared once again according to the M38-A2 method, and the suspensions were diluted 1:100 in YeastOne RPMI medium. The dried Sensititre YeastOne panels were rehydrated, 100 μl of the working suspension was added to each well, the panels covered with sealing strips, incubated at 35°C, and read after 48 and 72 h.
Colorimetric MIC were interpreted as the lowest concentration of antifungal solutions at which a change in colour from pink (growth) to blue (no growth) was observed.
Drug susceptibility test results
Drug susceptibility test results are summarized in Table 1 . Both A. persii strains appeared susceptible in vitro to itraconazole, voriconazole, posaconazole, and terbinafi ne with only slight differences found between the two methods.
Discussion
Non-dermatophytic moulds are an increasing cause of onychomycosis. The incidence of these infections is probably infl uenced by environmental conditions as case numbers are increasing in tropical and humid climatic regions [1] [2] [3] [4] [5] [10] [11] [12] .
As described in different reports, the most common species involved belong to the genera Scopulariopsis, Aspergillus, Acremonium and Fusarium [1, 4, 12, 13] . From a clinical point of view, there is no general agreement about differences in the manifestations of onychomycosis caused by dermatophytes and nondermatophytes [1, 4, 14] . However, the Aspergillus strains usually show a clear keratinophilic suffered from a reinfection or from a new infection in the same nail plate.
Other Aspergillus species described as agents of onychomycosis are A. terreus, A. fl avus and A. sclerotiorum, belonging to the sections Terrei, Flavi and Circumdati [10, 12, 13, [16] [17] [18] respectively.
The members of the section Circumdati, which includes A. sclerotiorum and A. persii, typically exhibit predominant biseriate conidial heads with yellow (or buff or ochraceus) colored conidia [19] . In particular, A. persii colonies on Sabouraud medium are pastel to light yellow in colour, with conidial heads loosely columnar to radiate, vesicles 10-25 μm in diameter, conidia globose and smooth 2.5-3 μm in diameter [6] . activity, which causes partial or total dystrophy of the affected nail [11] . According to the criteria provided by Gupta et al. in 2001 , positive cultures from repeated nail examinations are required to confi rm the diagnosis of nondermatophytic onychomycosis [15] .
Both our patients showed, to a variable degree, dystrophy of the affected nail plates and A. persii was repeatedly isolated in pure culture. Therefore we believe that the data clearly indicates that this fungus was responsible for the nail infections observed in our two patients. This conclusion was further supported by the recovery of the same fungus from relapse nail infections in the patients after three and ten years. Since the fungus is not a common pathogen, it is diffi cult to understand if our patients Therefore, on a strictly morphological basis, A. terreus and A. fl avus are easily distinguishable from A. persii. Indeed, when cultured on Sabouraud medium, colonies of A. terreus are in the brownish orange to camel colour range with compact columnar conidial heads and very small and smooth conidia (2-2.5 μm in diameter). In contrast, A. fl avus colonies are olive yellow to olive green, with smooth to fi nely roughened conidia (3-6 μm in diameter).
In contrast, A. persii is far more diffi cult to distinguish from A. sclerotiorum on the basis of morphologic characters as the key features of A. persii are only evident on certain substrates when grown at specifi c temperatures. Unlike A. sclerotiorum, A. persii scarcely grows on Czapek dox agar (Cz) not even after ten days as opposed to its better development on Czapek Yeast Agar (CYA) at 37°C, with abundant conidiogenesis similar to those obtained on CYA at 25°C. Moreover, A. persii does not show exudates on CYA at 25°C and the colonies reverse is coloured in red brown or orange brown on Cz, CYA and Malt Extract Agar (MEA).
Finally, the presence of septate club-like enlargements on hyphae [6] seems to be the most discriminating morphological character and was found with both strains. The occurrence of these enlargements on all culture media suggests they are typical of the species and not a mere morphological alteration of an opportunistic fungus (Fig. 3) .
It is possible to distinguish A. persii from A. sclerotiorum by means of DNA analysis, as reported by Frisvad et al. [7] and Peterson [20] . The use of molecular analysis meets the polyphasic approach (molecular, morphological, physiological and ecological data) recommended by Samson et al. [21] in order to describe a new Aspergillus species.
In conclusion, our case reports are the fi rst clinical descriptions of onychomycosis caused by A. persii. The fungi had previously been isolated and described for the fi rst time just from the fi rst clinical case [6, 16] .
Since the identifi cation of the etiologic agents of onychomycosis is generally only to the generic level, it is quite possible that other cases ascribed to yellow-colonies Aspergillus spp., might have actually been caused by A. persii [3] [4] [5] . As regards the antifungal susceptibility, the isolates were susceptible in vitro to itraconazole, voriconazole, posaconazole and terbinafi ne.
